PharmaNetics requests HDE (humanitarian device exemption) for anticoagulant test
This article was originally published in Clinica
Executive Summary
PharmaNetics has asked the US FDA for a humanitarian device exemption (HDE) allowing the company to market its Ecarin Clotting Time test for use in certain patients undergoing cardiopulmonary bypass.